What are the stages of macular hole on optical coherence tomography (OCT) images, and how is a pseudo‑operculum visualized and explained?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stages of Macular Hole on OCT

Macular holes progress through distinct stages on OCT imaging, with Stage 1 (impending holes with vitreous traction but no full-thickness defect), Stage 2 (small full-thickness holes with persistent vitreous attachment), Stage 3 (full-thickness holes with attached posterior hyaloid), and Stage 4 (full-thickness holes with complete posterior vitreous detachment). 1

Stage Classification System

The Gass classification system, validated and refined by OCT imaging, remains the standard for staging macular holes 1:

Stage 1: Impending Macular Hole (No Full-Thickness Defect)

  • Stage 1-A: Yellow spot at the fovea on biomicroscopy; OCT shows foveal detachment with vitreomacular traction (VMT) or vitreomacular adhesion (VMA) 1
  • Stage 1-B: Yellow ring at the fovea; OCT demonstrates centrifugal displacement of retinal receptors after dehiscence at the umbo, with contracted prefoveolar vitreous cortex potentially bridging the ring (occult hole) 2

Critical point: These are NOT true full-thickness holes—approximately 50% resolve spontaneously when vitreous detaches, while 40-50% progress to full-thickness holes 1

Stage 2: Small Full-Thickness Macular Hole

  • Full-thickness retinal defect <400 μm
  • Persistent vitreous attachment at or near the hole margin
  • OCT shows the hole may be eccentric with focal adherence visible at the margin 3
  • Approximately 75% progress to Stage 3 or 4 without intervention 1

Stage 3: Full-Thickness Macular Hole with Attached Hyaloid

  • Full-thickness hole with posterior hyaloid still attached to the retina (distinguishing feature from Stage 4)
  • OCT reveals three distinct subtypes 3:
    • Group 3A (21%): Hyaloid not visible anterior to retina but still adherent—can be confused with Stage 4 without B-scan ultrasonography
    • Group 3B (42%): Focal adherence visible at hole margin (similar appearance to Stage 2, but hole is larger, long-standing, and non-eccentric)
    • Group 3C (37%): Hyaloid detached from macular area but still attached elsewhere

B-scan ultrasonography is essential to distinguish Stage 3 from Stage 4 when OCT findings are ambiguous 3

Stage 4: Full-Thickness Macular Hole with Complete PVD

  • Full-thickness hole with complete posterior vitreous detachment
  • No vitreous attachment to the macula or optic disc
  • OCT shows clean separation of posterior hyaloid from retinal surface

Pseudo-Operculum: Understanding the Image

A pseudo-operculum is a prehole opacity that appears to float above the macular hole but contains NO retinal photoreceptors—only glial tissue (fibrous astrocytes and Müller cells) and vitreous collagen. 2, 4

OCT Characteristics of Pseudo-Operculum:

  • Hyperreflective opacity suspended in the vitreous cavity anterior to the macular hole
  • Attached to or associated with the posterior hyaloid membrane
  • May appear similar to a true operculum on clinical examination but differs histologically 2

Distinguishing Pseudo-Operculum from True Operculum:

Pseudo-operculum (61% of cases) 4:

  • Contains only glial cells (astrocytes and Müller cells)
  • Internal limiting membrane fragments present in 61%
  • Associated with foveal dehiscence rather than full-thickness tear
  • Better surgical outcomes: 82% initial closure rate 4

True operculum (39% of cases) 4:

  • Contains glia PLUS neurites and synaptic complexes (including cone photoreceptors)
  • Represents avulsed foveal tissue from full-thickness tear
  • Worse surgical outcomes: Only 14% initial closure rate 4
  • Indicates direct tractional forces caused tissue loss

Clinical Implications:

The presence of a pseudo-operculum on OCT suggests the hole formed through centrifugal displacement of receptors rather than direct avulsion, which carries prognostic significance. However, you cannot reliably distinguish pseudo-operculum from true operculum on OCT alone—this requires histopathologic examination 4. The practical takeaway: any operculum-like structure indicates a more advanced hole requiring surgical intervention.

Advanced OCT Staging Based on Outer Retinal Changes

A newer staging system focuses on sequential outer retinal morphologic changes at the hole borders, which correlates with symptom duration and visual outcomes 5:

  • Stage A: Intact external limiting membrane (ELM), ellipsoid zone (EZ), and interdigitation zone (7.7% of cases)
  • Stage B: Thickening of the EZ (52% of cases)
  • Stage C: Patchy "moth-eaten" photoreceptor loss (30.7% of cases)
  • Stage D: Severe/complete loss of photoreceptor inner and outer segments with bare ELM (9.6% of cases)

Stages B and C at surgery predict better 3-month visual outcomes than Stage D (P=0.04) 5. This system provides additional prognostic information beyond traditional Gass staging.

Common Pitfalls to Avoid

  1. Confusing Stage 3A with Stage 4: When the hyaloid is not visible on OCT but remains adherent, always obtain B-scan ultrasonography to confirm true PVD 3

  2. Assuming all opercula represent lost photoreceptors: Most are pseudo-opercula containing only glia, which have better surgical prognosis 4

  3. Missing Stage 1-B occult holes: The contracted prefoveolar vitreous cortex can hide a small hole, making it appear as only a yellow ring on examination 2

  4. Overlooking photoreceptor integrity: The visualization of the photoreceptor inner segment/outer segment (IS/OS) junction is a critical indicator of visual potential and should be assessed on all OCT images 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.